Company: SGBAF
Filing Date: 2025-01-17
Form Type: DRS/A
Source: 0000950123-25-000378
Chunk: 132

Company: SES S.A.
Filing Date: 2025-01-17
Form: DRS/A
Chunk 132
---
 not to assert that a remedy of monetary damages would provide an adequate remedy for any
breach or threatened breach of the Share Purchase Agreement. Notwithstanding anything to the contrary in the Share Purchase Agreement, the parties agreed that any action arising out of or pursuant to the specific performance provision in the Share
Purchase Agreement will be governed by, construed and enforced in accordance with the laws of the State of New York, regardless of the laws that might otherwise govern under applicable principles of conflicts of laws.

Waiver of Jury Trial

Each of Intelsat
and SES waived all right to a trial by jury in any action or claim arising out of any dispute in connection with the Share Purchase Agreement, any rights or obligations under the Share Purchase Agreement or the performance of any such rights or
obligations.

Non-Recourse

The Share Purchase Agreement may only be enforced against, and any claims, obligations, liabilities or actions that may be based upon, in
respect of, arise under, out or by reason of, be connected with, or relate in any manner to the Share Purchase Agreement or the transactions contemplated thereby, or the negotiation, execution, or performance of the Share Purchase Agreement may only
be made against, the parties to the Share Purchase Agreement.

84

Confidential Treatment Requested by SES

Pursuant to 17 C.F.R. Section 200.83

RELATED AGREEMENTS – CONTINGENT VALUE RIGHTS AGREEMENT

This section describes the material terms of the contingent value rights agreement, which will be entered into and executed between SES and Equiniti Trust Company, LLC, as Rights Agent, in connection with the Closing. The rights and obligations of the parties shall be governed by the express terms and conditions of the CVR Agreement, a form of which is attached hereto as Annex B, and not by this summary. This summary is not complete and is qualified in its entirety by reference to the complete text of the CVR Agreement. You are encouraged to read the CVR Agreement carefully in its entirety, as well as this prospectus and any documents incorporated by reference herein. This section is not intended to provide you with any factual information about either Intelsat or SES.

The CVR Agreement will set forth the terms of the CVRs to be issued to Intelsat at the Closing. A Holder is entitled to receive Applicable
Consideration (as defined below) pursuant to the terms and conditions of the CVR Agreement, less any applicable withholding taxes, upon SES’s receipt of Gross Proceeds (as defined